// App-Quantinova.ai

821 : Discrepancies between Clinical- and Imaging-Based Assessments of Disease Activity in Takayasu’s Arteritis

Researchers

Presenter

  • Peter C. Grayson

Principal Investigators

  • Mark Ahlman

  • Kathleen Marinelli

  • Renee Borchin

  • Simon Carette

  • Nader A. Khalidi

  • Carol A. Langford

  • Carol A. McAlear

  • Paul A. Monach

  • Christian Pagnoux

  • Kenneth J. Warrington

  • Steven R. Ytterberg

  • Peter A. Merkel

Medical Centers

  • National Institute of Arthritis and Musculoskeletal and Skin Disease, Bethesda, MD.

  • Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD

  • National Institute of Health, Bethesda, MD

  • University of South Florida, Tampa, FL

  • Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada

  • Rheumatology, McMaster University, Hamilton, ON, Canada

  • Rheumatic & Immunologic Dis, Cleveland Clinic Foundation, Cleveland, OH

  • University of Pennsylvania, Philadelphia, PA

  • Tufts University School of Medicine, Boston, MA

  • Hematology, Mayo Clinic, Rochester,

  • Biostatistics, Epidemiology, and Bioinformatics, University of Pennsylvania, Philadelphia, PA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • N/A

Biomarkers

  • 18F-fluorodeoxyglucose

  • C reactive protein

  • Estrogen receptor alpha

Drug/Treatment

  • Prednisone

  • Methadone hydrochloride

Outcome

  • N/A


Study Design

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A